You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CHRO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CHRO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CHRO is unprofitable, so we are unable to assess its PEG ratio
(NYSEMKT: CHRO) Chromocell Therapeutics trades on the NYSEMKT under the ticker symbol CHRO. Chromocell Therapeutics stock quotes can also be displayed as NYSEMKT: CHRO.
What is the 52 week high and low for Chromocell Therapeutics (NYSEMKT: CHRO)?
(NYSEMKT: CHRO) Chromocell Therapeutics's 52-week high was $6.00, and its 52-week low was $1.21. It is currently -73.33% from its 52-week high and 32.23% from its 52-week low.
How much is Chromocell Therapeutics's stock price per share?
(NYSEMKT: CHRO) Chromocell Therapeutics stock price per share is $1.60 today (as of Apr 26, 2024).
What is Chromocell Therapeutics's Market Cap?
(NYSEMKT: CHRO) Chromocell Therapeutics's market cap is $9.40M, as of Apr 27, 2024.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Chromocell Therapeutics's market cap is calculated by multiplying CHRO's current stock price of $1.60 by CHRO's total outstanding shares of 5,877,835.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.